Johnathan M. Lancaster

Johnathan M. Lancaster, MD PhD, currently serves as the President and Chief Scientific Officer at Truveta. Previously, they held multiple prominent roles at Moffitt Cancer Center from 2008 to 2015, including President of the Moffitt Medical Group and Chair of the Department of Women's Oncology. Their experience also includes positions at Myriad Genetics, Inc. and Regeneron Pharmaceuticals, Inc., where they advanced to Senior Vice President & Head of Global Medical Affairs. Educated at the University of Wales, Johnathan earned degrees in Molecular Genetics, Medicine, and a Bachelor's in Pharmacology, and is a current resident in Obstetrics & Gynaecology at the University of Cambridge.